Siemens Healthcare Diagnostics, Inc.: Device Recall

Recall #Z-1551-2025 · 03/11/2025

Class II: Risk

Recall Details

Recall Number
Z-1551-2025
Classification
Class II
Product Type
Device
Recalling Firm
Siemens Healthcare Diagnostics, Inc.
Status
Ongoing
Date Initiated
03/11/2025
Location
Tarrytown, NY, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
N/A

Reason for Recall

Incorrect software flagging may occur for the assay that may potentially lead to an erroneous result.

Product Description

Atellica CH Revised C Reactive Protein (RCRP); Siemens Material Number (SMN): 11537223.

Distribution Pattern

Domestic: Nationwide Distribution. International: Australia, Austria, Bahamas, Bahrain, Belgium, Brazil, Canada, Chile, China, Colombia, Croatia, Cura¿ao,¿St¿Eus, Czech¿Republic, Denmark,¿Estonia, Finland, France, Germany, Greece,¿Hong Kong, Hungary, India, Ireland, Israel, Italy, Korea, Kuwait, Latvia, Lithuania, Malaysia, Maldives, Netherlands, New Zealand, Norway, Oman,¿Pakistan, Poland, Portugal, Qatar, Romania, Saudi¿Arabia, Serbia, Singapore, Slovakia, Slovenia, South¿Africa, Spain, Sweden, Switzerland, Taiwan, U.A.E., Uganda, United¿Kingdom, Uzbekistan, Vatikancity.¿ ¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿ ¿¿¿¿¿¿¿ ¿ ¿¿¿¿ ¿¿¿¿¿¿ ¿¿¿¿¿¿¿¿¿¿ ¿¿¿¿¿¿¿¿ ¿¿¿¿¿ ¿ ¿¿¿¿¿¿

Other Recalls by Siemens Healthcare Diagnostics, Inc.

View all recalls by Siemens Healthcare Diagnostics, Inc. →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.